ESE
$94.01
Esco Technologies
$2.21
2.41%
Earnings Details
Quarter September 2022
Thursday, November 17, 2022 4:15:00 PM
Tweet Share Watch
Summary

ESCO Technologies Provides Mixed Guidance

Esco Technologies (ESE) reported Quarter September 2022 earnings of $1.21 per share on revenue of $256.5 million. The consensus earnings estimate was $1.15 per share. Revenue grew 24.8% on a year-over-year basis.

The company said it expects first quarter non-GAAP earnings of $0.46 to $0.52 per share. The current consensus earnings estimate is $0.60 per share for the quarter ending December 31, 2022. The company said it expects fiscal 2023 non-GAAP earnings of $3.45 to $3.60 per share on revenue of $910.0 million to $930.0 million. The current consensus earnings estimate is $3.66 per share on revenue of $885.1 million for the year ending September 30, 2023.

ESCO Technologies Inc designs and manufactures specialty filtration products including hydraulic filter elements and fluid control devices used in commercial aerospace applications, filter mechanisms used in micro-propulsion devices for satellites.

Results
Reported Earnings
$1.21
Earnings Whisper
-
Consensus Estimate
$1.15
Reported Revenue
$256.5 Mil
Revenue Estimate
Growth
Earnings Growth
Revenue Growth
Power Rating
Grade
Earnings Release

ESCO Announces Record Fourth Quarter and Fiscal 2022 Results

St. Louis, Nov. 17, 2022 (GLOBE NEWSWIRE) -- ESCO Technologies Inc. (NYSE: ESE) (ESCO, or the Company) today reported its operating results for the fourth quarter (Q4 2022) and fiscal year (FY 2022) ended September 30, 2022.

Operating Highlights

  • Q4 2022 GAAP EPS increased $0.41 per share (53 percent) to $1.19 per share compared to $0.78 per share in Q4 2021.   Q4 2022 Adjusted EPS increased $0.36 per share (42 percent) to $1.21 per share compared to $0.85 per share in Q4 2021.
  • FY 2022 GAAP EPS increased $0.74 per share (31 percent) to $3.16 per share compared to $2.42 per share in FY 2021. FY 2022 Adjusted EPS increased $0.62 per share (24 percent) to $3.21 per share compared to $2.59 per share in FY 2021.
  • Q4 2022 sales increased $51 million (25 percent) to $256 million compared to $205 million in Q4 2021. Organic sales increased $38 million (19 percent) and recent acquisitions added $13 million (6 percent) of revenue growth in the quarter.
  • FY 2022 sales increased $142 million (20 percent) to $858 million. Organic sales increased $90 million (13 percent) and recent acquisitions added $52 million (7 percent) of revenue growth for the full year.   
  • Q4 2022 entered orders decreased $14 million (5 percent) compared to the prior year period to $245 million (book-to-bill of 0.95x). Full year 2022 entered orders increased $164 million (21 percent) to $961 million (book-to-bill of 1.12x) and resulted in record year-end backlog of $695 million.
  • Net cash provided by operating activities was $94 million in Q4 and $135 million for the full year, resulting in an increase of $12 million (10 percent) over the prior year.  
  • Net debt (total borrowings less cash on hand) was $55 million, resulting in a leverage ratio of 0.78x and $589 million in available liquidity on September 30, 2022.

FY 2022 was a record year for sales, Adjusted EBIT, Adjusted EPS, cash flow from operations, entered orders, and year-end backlog.   Entered orders were strong across our end-markets, with all three business segments reporting a book-to-bill greater than 1.1x.   Overall, entered orders increased 21 percent compared to the prior year and drove record year-end backlog of $695 million.   Cash flow from operations was $135 million with a 108 percent free cash flow conversion rate.   Recovery in key end-markets combined with solid orders momentum drove meaningful growth and improved operating results during the year.

Vic Richey, Chairman and Chief Executive Officer, commented, “Given the continuing economic disruptions and global headwinds throughout the year, I am very pleased that we were able to deliver outstanding results from both a growth and profitability perspective. Despite considerable challenges, we were able to exceed our commitments as communicated at the start of the year. ESCO is an industry leader that serves healthy end-markets, and through the tremendous efforts of our employees we were able to deliver results we are all very proud of in 2022.”

Segment Performance

Aerospace & Defense (A&D)

  • Q4 2022 sales increased $24 million (30 percent) to $104 million from $80 million in Q4 2021. Q4 sales growth was the result of strong demand across our commercial and defense aerospace, Navy, and space platforms.   FY 2022 sales increased $37 million (12 percent) to $351 million, largely driven by commercial aerospace, which increased $30 million (32 percent) to $123 million. Higher Navy and space sales were partially offset by lower industrial sales compared to the prior year.
  • Q4 2022 EBIT increased $8.7 million to $23.3 million from $14.6 million in Q4 2021. Adjusted EBIT increased $8.9 million in Q4 2022 to $23.6 million (22.7 percent margin) from $14.7 million (18.3 percent margin) in Q4 2021. FY 2022 EBIT increased $11.9 million to $68.4 million from $56.5 million in FY 2021. FY 2022 Adjusted EBIT increased $12.0 million to $69.0 million (19.6 percent margin) from $57.0 million (18.1 percent margin) in FY 2021. Margin increases for the quarter and year were driven by higher volumes and price increases, partially offset by inflationary pressures.  
  • Entered Orders increased $9 million to $97 million in Q4 2022.   For the full year entered orders increased $55 million (16 percent) to $392 million (book-to-bill of 1.12). The orders strength was primarily driven by the continuing recovery of commercial aerospace and resulted in record year-end backlog of $408 million.

Utility Solutions Group (USG)

  • Q4 sales increased $22 million (37 percent) to $83 million from $61 million in Q4 2021. Organic sales increased $12 million (21 percent) and recent acquisitions Phenix and Altanova contributed $10 million in revenue.   FY 2022 sales increased $75 million (37 percent) to $278 million from $203 million in FY 2021. Doble organic sales increased $20 million (12 percent), NRG sales increased $8 million (24 percent), and Phenix and Altanova added $47 million, The organic sales growth was driven by increased electric utility spending and strong demand across our renewables product lines.
  • Q4 2022 EBIT increased $6.5 million to $19.8 million from $13.3 million in Q4 2021. Adjusted EBIT increased $4.9 million in Q4 2022 to $19.8 million (23.7 percent margin) from $14.9 million (24.3 percent margin) in Q4 2021. FY 2022 EBIT increased $16.7 million to $57.6 million from $40.9 million in FY 2021. FY 2022 Adjusted EBIT increased $15.7 million to $58.1 million (20.9 percent margin) from $42.4 million (20.9 percent margin) in FY 2021. Adjusted EBIT increases for the quarter and year were largely driven by higher volumes and price increases, partially offset by inflationary pressures, increased travel and conference costs.  
  • Entered Orders decreased $8 million to $88 million in Q4 2022. Orders for the quarter were lower due to the timing of orders booked related to the backlog acquired with the Phenix and Altanova transactions in Q4 2021. For the full year entered orders increased $71 million to $315 million (book-to-bill of 1.13) and resulted in year-end backlog of $128 million. Orders strength was driven by contributions from Altanova and Phenix, increased electric utility spending and continuing growth in the demand for renewables.  

Test

  • Q4 2022 sales increased $5 million (8 percent) to $69 million from $64 million in Q4 2021, primarily due to increased medical and industrial shielding and power filter demand.   FY 2022 sales increased $30 million (15 percent) to $228 million, driven by increased test and measurement projects, medical and industrial shielding, and power filter demand.
  • Q4 2022 EBIT increased $1.9 million to $11.8 million (17.0 percent margin) from $9.9 million (15.3 percent margin) in Q4 2021. FY 2022 EBIT increased $5.0 million to $32.6 million (14.3 percent margin) from $27.6 million (14.0 percent margin) in FY 2021. The increase in profitability was driven by leverage on higher sales and price increases, partially offset by material cost and wage inflation.
  • Entered Orders decreased $14 million to $59 million in Q4 2022. Orders were lower during the quarter primarily due to the timing of large power filter orders in Q4 2021. For the full year entered orders increased $38 million to $253 million (book-to-bill of 1.11) and resulted in record year-end backlog of $159 million. The orders strength was driven by medical shielding and global demand for test and measurement projects.

Share Repurchase Program
The Company did not repurchase any shares of stock during Q4 2022. During FY 2022 the Company repurchased approximately 257,500 shares for $20 million.

Dividend Payment
The next quarterly cash dividend of $0.08 per share will be paid on January 20, 2023 to stockholders of record on January 5, 2023.

2023 Annual Meeting
The 2023 Annual Meeting of the Company’s Shareholders will be held on February 3, 2023.

Business Outlook – FY 2023
Management expects continued growth in sales, Adjusted EBIT, and Adjusted EBITDA across each of the Company’s business segments in 2023.

Management’s expectations for growth in 2023 compared to 2022:

  • Net sales are expected to grow 6 to 8 percent and be in the range of $910 to $930 million on a consolidated basis, with A&D growing 10 to 13 percent, USG growing 5 to 7 percent, and Test growing 3 to 5 percent.
  • Adjusted EBIT is expected to increase approximately 10 to 15 percent with Adjusted EBIT margins increasing to 13.5 to 14.0 percent of sales.
  • Adjusted EBITDA is expected to increase approximately 7 to 12 percent with Adjusted EBITDA margins increasing to 19.0 to 19.5 percent of sales.
  • Interest expense is expected to increase approximately $4.3 million to over $9 million (due to higher interest rates) excluding the impact of any future acquisitions.
  • The effective income tax rate is expected to be in the range of 22.5 to 23.5 percent in 2023.
  • Management projects 2023 Adjusted EPS to increase 7.5 to 12 percent and be in the range of $3.45 to $3.60 per share. This projection reflects margin expansion on the anticipated sales growth, partially offset by increased interest expense.
  • Management expects flat to slightly up Adjusted EPS of $0.46 - $0.52 in Q1 2023 compared to the prior year. Consistent with prior years, revenues and Adjusted EPS are expected to grow sequentially throughout the year.

Management Transition
As previously announced, Vic Richey will be retiring from his roles as CEO and President at the end of the calendar year. Mr. Richey will continue as Executive Chairman of the Board during a transition period as current USG President Bryan Sayler assumes the roles of ESCO CEO and President. Richey commented “It’s been a pleasure to work at ESCO for 37 years and an honor to serve as CEO for the past 20 years. We have accomplished a lot during this time, and I am very thankful to our employees who have shown extreme dedication and effort over the years. I’d also like to thank our Board of Directors for their ongoing support of the Company as we worked to create what ESCO is today. I’m very excited about the future of the Company. Bryan has over 25 years of leadership experience at ESCO and is uniquely qualified to lead the company moving forward.” Mr. Sayler is currently transitioning from his position as President of the USG segment and will assume the positions of CEO and President of ESCO on January 1, 2023. “As I step into my new role at ESCO, I’m excited for the opportunity to lead this vibrant organization as we continue to build upon the strong foundation established under Vic’s leadership,” said Sayler.

Conference Call
The Company will host a conference call today, November 17, at 4:00 p.m. Central Time, to discuss the Company’s Q4 and full year 2022 results. A live audio webcast and an accompanying slide presentation will be available on ESCO’s investor website at https://investor.escotechnologies.com. For those unable to participate, a webcast replay will be available after the call on ESCO’s investor website.

Forward-Looking Statements
Statements in this press release regarding the timing and magnitude of recovery in the Company’s end markets, the continuing impacts of COVID-19 on the Company’s results, sales, Adjusted EBIT, Adjusted EBITDA, Adjusted EPS, cash flow, results of cost reduction efforts, margins, growth, the financial success of the Company, the strength of its end markets, the outlook for the A&D, Test and USG segments, the ability to increase shareholder value, the timing and success of acquisition efforts, internal investments in new products and solutions, the impacts of inflation, the long-term success of the Company, and any other statements which are not strictly historical are “forward-looking” statements within the meaning of the safe harbor provisions of the federal securities laws.

Investors are cautioned that such statements are only predictions and speak only as of the date of this release, and the Company undertakes no duty to update them except as may be required by applicable laws or regulations. The Company’s actual results in the future may differ materially from those projected in the forward-looking statements due to risks and uncertainties that exist in the Company’s operations and business environment including but not limited to those described in Item 1A, “Risk Factors”, of the Company’s Annual Report on Form 10-K for the fiscal year ended September 30, 2021; the availability and acceptance of viable COVID-19 vaccines by enough of the U.S. and world’s population to curtail the pandemic; the continuing impact of the COVID-19 pandemic and the effects of known or unknown COVID-19 variants including labor shortages, facility closures, shelter in place policies or quarantines, material shortages, transportation delays, termination or delays of Company contracts, and the inability of our suppliers or customers to perform; the impacts of Executive Order 14042 and other vaccine mandates on our employees and businesses; the impacts of natural disasters on the Company’s operations and those of the Company’s customers and suppliers; the timing and content of future contract awards or customer orders; the appropriation, allocation and availability of Government funds; the termination for convenience of Government and other customer contracts or orders; weakening of economic conditions in served markets; the success of the Company’s competitors; changes in customer demands or customer insolvencies; competition; intellectual property rights; technical difficulties; the success of the Company’s acquisition efforts; delivery delays or defaults by customers; performance issues with key customers, suppliers and subcontractors; changes in the costs and availability of certain raw materials; labor disputes; changes in U.S. tax laws and regulations; other changes in laws and regulations including but not limited to changes in accounting standards and foreign taxation; changes in interest rates; costs relating to environmental matters arising from current or former facilities; uncertainty regarding the ultimate resolution of current disputes, claims, litigation or arbitration; and the integration of recently acquired businesses.

Non-GAAP Financial Measures
The financial measures EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are presented in this press release. The Company defines “EBIT” as earnings before interest and taxes, “EBITDA” as earnings before interest, taxes, depreciation and amortization, “Adjusted EBIT” and “Adjusted EBITDA” as excluding the net impact of the items described in the attached Reconciliation of Non-GAAP Financials Measures, and “Adjusted EPS” as GAAP earnings per share excluding the net impact of the items described and reconciled in the attached Reconciliation of Non-GAAP Financial Measures.

EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS are not recognized in accordance with U.S. generally accepted accounting principles (GAAP). However, Management believes EBIT, Adjusted EBIT, EBITDA, and Adjusted EBITDA are useful in assessing the operational profitability of the Company’s business segments because they exclude interest, taxes, depreciation, and amortization, which are generally accounted for across the entire Company on a consolidated basis. EBIT is also one of the measures used by Management in determining resource allocations within the Company as well as incentive compensation. The presentation of EBIT, Adjusted EBIT, EBITDA, Adjusted EBITDA, and Adjusted EPS provides important supplemental information to investors by facilitating comparisons with other companies, many of which use similar non-GAAP financial measures to supplement their GAAP results. The use of non-GAAP financial measures is not intended to replace any measures of performance determined in accordance with GAAP.

ESCO is a global provider of highly engineered products and solutions serving diverse end-markets. It manufactures filtration and fluid control products for the aviation, Navy, space, and process markets worldwide and composite-based products and solutions for Navy, defense, and industrial customers. ESCO is the industry leader in RF shielding and EMC test products; and provides diagnostic instruments, software and services to industrial power users and the electric utility and renewable energy industries. Headquartered in St. Louis, Missouri, ESCO and its subsidiaries have offices and manufacturing facilities worldwide. For more information on ESCO and its subsidiaries, visit the Company’s website at www.escotechnologies.com.
   

    ESCO TECHNOLOGIES INC. AND SUBSIDIARIES 
Condensed Consolidated Statements of Operations (Unaudited) 
(Dollars in thousands, except per share amounts) 
   
     Three Months
Ended
September 30,
2022
 Three Months
Ended
September 30,
2021
  
          
Net Sales $256,498 205,478  
Cost and Expenses:      
 Cost of sales 154,323 128,260  
 Selling, general and administrative expenses 53,054 44,906  
 Amortization of intangible assets 6,553 6,100  
 Interest expense 1,767 802  
 Other (income) expenses, net 373 371  
  Total costs and expenses 216,070 180,439  
          
Earnings before income taxes 40,428 25,039  
Income tax expense 9,388 4,674  
          
  Net earnings$31,040 20,365  
          
  Diluted EPS:      
  Diluted - GAAP      
   Net earnings$1.19 0.78  
          
  Diluted - As Adjusted Basis      
   Net earnings$1.21(1)0.85(2) 
          
  Diluted average common shares O/S: 25,990 26,232  
          
(1)Q4 2022 Adjusted EPS excludes $0.02 per share of after-tax severance charges at VACCO and NRG and Corporate management transition costs.
          
(2)Q4 2021 Adjusted EPS excludes $0.07 per share of after-tax charges mainly consisting of purchase accounting adjustments related to the Phenix & Altanova acquisitions, acquisition costs at Corporate, and restructuring costs primarily within the USG segment.

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES 
Condensed Consolidated Statements of Operations (Unaudited) 
(Dollars in thousands, except per share amounts) 
   
     Year Ended
September 30,
2022
 Year Ended
September 30,
2021
 
         
Net Sales $857,502  715,440  
Cost and Expenses:     
 Cost of sales 525,457  445,045  
 Selling, general and administrative expenses 195,127  167,534  
 Amortization of intangible assets 25,936  20,829  
 Interest expense 4,851  2,255  
 Other (income) expenses, net (304) (894) 
  Total costs and expenses 751,067  634,769  
         
Earnings before income taxes 106,435  80,671  
Income tax expense 24,115  17,175  
         
  Net earnings$82,320  63,496  
         
  Diluted EPS:     
  Diluted - GAAP     
   Net earnings$3.16  2.42  
         
  Diluted - As Adjusted Basis     
   Net earnings$3.21 (1)2.59 (2)
         
  Diluted average common shares O/S: 26,067  26,225  
         
(1)FY 2022 Adjusted EPS excludes $0.05 per share of after-tax charges associated with the Altanova & Neco acquisition inventory step-up charges, severance charges at VACCO and NRG, Corporate acquisition costs and management transition costs.
         
(2)FY 2021 Adjusted EPS excludes $0.17 per share of after-tax charges mainly consisting of management transition and acquisition costs at Corporate, restructuring costs primarily within the USG segment, and purchase accounting adjustments related to the Phenix & Altanova acquisitions, partially offset by the final settlement from the sale of the Doble Watertown facility.

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Business Segment Information (Unaudited)
(Dollars in thousands)
   
    GAAP As Adjusted 
    Q4 2022 Q4 2021 Q4 2022 Q4 2021 
Net Sales          
 Aerospace & Defense$103,742  80,105  103,742  80,105  
 USG 83,490  61,107  83,490  61,107  
 Test 69,266  64,266  69,266  64,266  
  Totals$256,498  205,478  256,498  205,478  
            
EBIT           
 Aerospace & Defense$23,310  14,557  23,590  14,657  
 USG 19,764  13,264  19,813  14,874  
 Test 11,779  9,855  11,779  9,855  
 Corporate (12,658) (11,835) (12,428) (11,181) 
  Consolidated EBIT 42,195  25,841  42,754  28,205  
  Less: Interest expense (1,767) (802) (1,767) (802) 
  Less: Income tax expense (9,388) (4,674) (9,517) (5,218) 
  Net earnings$31,040  20,365  31,470  22,185  
               
Note 1: Adjusted net earnings of $31.5 million in Q4 2022 exclude $0.4 million (or $0.02 per share) of after-tax severance charges at VACCO and NRG, and Corporate management transition costs.
            
Note 2: Adjusted net earnings of $22.2 million in Q4 2021 exclude $1.8 million (or $0.07 per share) of after-tax charges mainly consisting of purchase accounting adjustments related to the Phenix & Altanova acquisitions, and acquisition costs at Corporate.
            
EBITDA Reconciliation to Net earnings:     Adjusted Adjusted 
    Q4 2022 Q4 2021 Q4 2022 Q4 2021 
Consolidated EBITDA$54,291  37,631  54,850  39,995  
Less: Depr & Amort (12,096) (11,790) (12,096) (11,790) 
Consolidated EBIT 42,195  25,841  42,754  28,205  
Less: Interest expense (1,767) (802) (1,767) (802) 
Less: Income tax expense (9,388) (4,674) (9,517) (5,218) 
Net earnings$31,040  20,365  31,470  22,185  
            

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Business Segment Information (Unaudited)
(Dollars in thousands)
   
    GAAP As Adjusted 
    FY 2022 FY 2021 FY 2022 FY 2021 
Net Sales          
 Aerospace & Defense$351,413  314,824  351,413  314,824  
 USG 278,367  202,908  278,367  202,908  
 Test 227,722  197,708  227,722  197,708  
  Totals$857,502  715,440  857,502  715,440  
            
EBIT           
 Aerospace & Defense$68,352  56,536  68,967  57,021  
 USG 57,604  40,948  58,120  42,427  
 Test 32,592  27,636  32,592  27,636  
 Corporate (47,262) (42,194) (46,727) (38,167) 
  Consolidated EBIT 111,286  82,926  112,952  88,917  
  Less: Interest expense (4,851) (2,255) (4,851) (2,255) 
  Less: Income tax (24,115) (17,175) (24,499) (18,553) 
  Net earnings$82,320  63,496  83,602  68,109  
               
Note 1: Adjusted net earnings of $83.6 million in FY 2022 exclude $1.3 million (or $0.05 per share) of after-tax charges associated with the Altanova & Neco acquisition inventory step-up charges, severance charges at VACCO and NRG, and Corporate acquisition and management transition costs.
            
Note 2: Adjusted net earnings of $68.1 million in FY 2021 exclude $4.6 million ($0.17 per share) of after-tax charges mainly consisting of management transition and acquisition costs at Corporate, restructuring costs primarily within the USG segment, and purchase accounting adjustments related to the Phenix & Altanova acquisitions, partially offset by the final settlement from the sale of the Doble Watertown facility.
            
EBITDA Reconciliation to Net earnings:    Adjusted Adjusted 
    FY 2022 FY 2021 FY 2022 FY 2021 
Consolidated EBITDA$159,629  124,975  161,295  130,966  
Less: Depr & Amort (48,343) (42,049) (48,343) (42,049) 
Consolidated EBIT 111,286  82,926  112,952  88,917  
Less: Interest expense (4,851) (2,255) (4,851) (2,255) 
Less: Income tax expense (24,115) (17,175) (24,499) (18,553) 
Net earnings$82,320  63,496  83,602  68,109  
            

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets (Unaudited)
(Dollars in thousands)
   
    September 30,
2022
 September 30,
2021
       
Assets     
 Cash and cash equivalents$97,724 56,232
 Accounts receivable, net 164,645 146,341
 Contract assets 125,154 93,771
 Inventories 162,403 147,148
 Other current assets 22,696 22,662
  Total current assets 572,622 466,154
 Property, plant and equipment, net 155,973 154,265
 Intangible assets, net 394,464 409,250
 Goodwill 492,709 504,853
 Operating lease assets 29,150 31,846
 Other assets 9,538 10,977
   $1,654,456 1,577,345
       
Liabilities and Shareholders' Equity    
 Current maturities of long-term debt$20,000 20,000
 Accounts payable 78,746 56,669
 Contract liabilities 125,009 106,045
 Other current liabilities 94,374 92,281
  Total current liabilities 318,129 274,995
 Deferred tax liabilities 82,023 73,560
 Non-current operating lease liabilities 24,853 28,032
 Other liabilities 48,294 47,062
 Long-term debt 133,000 134,000
 Shareholders' equity 1,048,157 1,019,696
   $1,654,456 1,577,345

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES  
Consolidated Statements of Cash Flows  
(Dollars in thousands)  
     
  Year Ended
September 30,
2022
 Year Ended
September 30,
2021
Cash flows from operating activities:    
Net earnings$82,320  63,496 
Adjustments to reconcile net earnings to net cash    
provided by operating activities:    
Depreciation and amortization 48,343  42,049 
Stock compensation expense 7,320  6,914 
Changes in assets and liabilities (11,654) 15,671 
Gain on sale of building and land 0  (1,950)
Effect of deferred taxes 8,946  (3,041)
Net cash provided by operating activities 135,275  123,139 
     
Cash flows from investing activities:    
Acquisition of business, net of cash acquired (10,906) (168,903)
Capital expenditures (32,101) (26,705)
Additions to capitalized software (12,912) (8,783)
Proceeds from sale of building and land 0  1,950 
Net cash used by investing activities (55,919) (202,441)
     
Cash flows from financing activities:    
Proceeds from long-term debt 116,000  216,000 
Principal payments on long-term debt and short-term borrowings (117,000) (124,368)
Dividends paid (8,268) (8,336)
Purchases of common stock into treasury (19,878) 0 
Other (2,976) (1,823)
Net cash (used) provided by financing activities (32,122) 81,473 
     
Effect of exchange rate changes on cash and cash equivalents (5,742) 1,501 
     
Net increase in cash and cash equivalents 41,492  3,672 
Cash and cash equivalents, beginning of period 56,232  52,560 
Cash and cash equivalents, end of period$97,724  56,232 

   
   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Other Selected Financial Data (Unaudited)
(Dollars in thousands)
   
Backlog And Entered Orders - Q4 2022 Aerospace & Defense USG Test Total
 Beginning Backlog - 7/1/22$414,521  123,850  168,429  706,800 
 Entered Orders 97,490  87,796  59,434  244,720 
 Sales  (103,742) (83,490) (69,266) (256,498)
 Ending Backlog - 9/30/22$408,269  128,156  158,597  695,022 
           
           
           
Backlog And Entered Orders - FY 2022 Aerospace & Defense USG Test Total
 Beginning Backlog - 10/1/21$367,216  91,631  133,176  592,023 
 Entered Orders 392,466  314,892  253,143  960,501 
 Sales  (351,413) (278,367) (227,722) (857,502)
 Ending Backlog - 9/30/22$408,269  128,156  158,597  695,022 

   
   

   

ESCO TECHNOLOGIES INC. AND SUBSIDIARIES
Reconciliation of Non-GAAP Financial Measures (Unaudited)
   
EPS – Adjusted Basis Reconciliation – Q4 2022  
 EPS – GAAP Basis – Q4 2022$1.19
 Adjustments (defined below) 0.02
 EPS – As Adjusted Basis – Q4 2022$1.21
    
 Adjustments exclude $0.02 per share consisting of after-tax severance charges  
 at VACCO and NRG and Corporate management transition costs.  
 The $0.02 of EPS adjustments per share consists of $0.6 million of pre-tax charges  
 offset by $0.2 million of tax benefit for net impact of $0.4 million.  
    
EPS – Adjusted Basis Reconciliation – FY 2022  
 EPS – GAAP Basis – FY 2022$3.16
 Adjustments (defined below) 0.05
 EPS – As Adjusted Basis – FY 2022$3.21
    
 Adjustments exclude $0.05 per share consisting of Altanova & Neco acquisition inventory
 step-up charges, severance charges at VACCO and NRG, Corporate acquisition costs and
 management transition costs.  
 The $0.05 of EPS adjustments per share consists of $1.7 million of pre-tax charges  
 offset by $0.4 million of tax benefit for net impact of $1.3 million  
    
EPS – Adjusted Basis Reconciliation – Q4 2021  
 EPS GAAP Basis – Q4 2021$0.78
 Adjustments (defined below) 0.07
 EPS – As Adjusted Basis – Q4 2021$0.85
    
 Adjustments exclude $0.07 per share consisting of purchase accounting adjustments,  
 acquisition costs at Corporate, and restructuring costs primarily within the USG segment. 
 The $0.07 of EPS adjustments per share consists of $2.3 million of pre-tax charges  
 offset by $0.5 million of tax benefit for net impact of $1.8 million.  
    
EPS – Adjusted Basis Reconciliation – FY 2021  
 EPS – GAAP Basis – FY 2021$2.42
 Adjustments (defined below) 0.17
 EPS – As Adjusted Basis – FY 2021$2.59
    
 Adjustments exclude $0.17 per share consisting of management transition and acquisition 
 costs, restructuring costs primarily within the USG segment, and purchase accounting  
 adjustments partially offset by the settlement from sale of Doble Watertown facility.  
 The $0.17 of EPS adjustments per share consists of $6.0 million of pre-tax charges  
 offset by $1.4 million of tax benefit for net impact of $4.6 million.  

   
   
SOURCE ESCO Technologies Inc.
Kate Lowrey, Vice President of Investor Relations, (314) 213-7277



Source: ESCO Technologies Inc.